NTCYF yields 4.13% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, NTCYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NTCYF + JNJ for your $10,000?
Netcompany Group A/S, an IT services company, delivers business critical IT solutions to public and private sector customers in Denmark, Norway, the United Kingdom, the Netherlands, Belgium, Luxembourg, Greece, Spain, and internationally. It is involved in the development, maintenance, and operation of business-critical IT solutions for various areas, such as digital Web and self-service solutions, application development, cognitive computing, e-commerce and product information management (PIM), ERP, CRM and marketing, application management, case and document management, operation and infrastructure, data and insight, application and mobile, and organizational implementation. The company serves customers in finance, government, manufacturing and engineering, municipality, organization, region, retail and trade, service, unemployment insurance fund and union, telecommunication and media, and energy and utility markets. Netcompany Group A/S was founded in 2000 and is headquartered in Copenhagen, Denmark.
Full NTCYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.